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MHC-encoded class I antigens are found on the surface of the majority of
nucleated mammalian cells and play a central role in the immunosurveillance
process whereby virus-infected or malignant cells are destroyed by cytotoxic T
lymphocytes (CTLs). Class I antigens are highly polymorphic and consist of a
polypeptide chain of ---46 kD organized into three extracellular domains of -92
residues each (termed N, C1 and C2, numbering from the NH 3 terminus), a
transmembrane region, and an intracellular domain (1). This chain is associated
noncovalently with the 12 kD polypeptide 02-microglobulin (02m)' through its
C2 domain. Close structural homology between immunoglobulins and the C2
domain of class I antigens, a2m, and the membrane-proximal domains of both
chains ofthe class II MHC antigens has been inferred from the well-established
sequence homologies between these members of the immunoglobulin superfam-
ily (2, 3), and in the case of a2m, has been shown crystallographically (4). Until
recently, however, little was known about the tertiary structure ofthe N and C1
domains of class I antigens, which manifest the majority of the sequence poly-
morphism and are much less homologous to immunoglobulin than is the C2
domain. Although the C1 domain contains a disulfide bond enclosing a loop of
63 residues, the position of the two cysteines are not homologous to their
counterparts in immunoglobulins.
The two membrane-distal domains, N and C1, are the most important for the
immunological function ofthe class I antigens. The sites within class I molecules
responsible for recognition by both monoclonal antibodies (mAbs) and CTLs
have been partially localized and shown to predominantly reside in these two
domains (5-12) . Much of the localization of mAb and CTL epitopes has used
hybrid class I molecules produced by the expression in mouse L cells of recom-
binant genes in which the exons encoding the individual external domains have
been exchanged (5-12) . In this work, a new family ofhybrid genes wasgenerated
' Abbreviation used in this paper: ,82m, f'2-microglobulin.
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in which exons encoding the N, C 1, and C2 domains were exchanged between
the cloned H-2Dd (5) and H-2DP (13) genes to produce four of the six possible
recombinant permutations. Studies with these new recombinant gene products
allowed the analysis in some detail of the conformational determinants created
by the interaction between the N and C 1 domains of class I antigens . The
specificities of a large panel of anti-H-2D' mAbs, the epitopes of which had been
assigned to one or both of the distal domains on the basis of experiments with
H-2Dd/H-2Ld recombinants (12) and a number of anti-H-2DP mAbs were ex-
amined using the H-2Dd/H-2DP recombinants. This analysis revealed that a
number of epitopes recognized by the anti-H-2Dd mAbs, previously localized to
the N domain, were modified by substitutions in the CI domain. By comparing
the primary structures of the C l domains of the Dd, Ld, and DP molecules, a
small number of candidate residues in the C1 domain responsible for this effect
were identified. A high proportion of the anti H-2DP mAbs also recognized
epitopes involving both domains.
The high frequency with which CTLs and mAbs recognize complex determi-
nants dependent upon both N and C 1 domains observed here and in other
studies (7-9), along with the many distinct patterns ofcrossreactivity of the mAbs
used here with other class I molecules, suggests an extensive area of interaction
between these two domains which is of central importance to the function of
class I molecules. This idea is supported by the recent findings on the crystallo-
graphic structure of a human class I antigen (Samraoui, B., P. Bjorkman, and D.
Wiley, Department of Biochemistry and Molecular Biology, Harvard University,
Cambridge, MA, personal communication).
Materials and Methods
Preparation ofRecombinant Genes.
￿
Plasmid pDd-1 (5) was digested to completion with
Xba I giving a 1 .8 kb fragment containing exons I, 2, and 3, and a 12 kb fragment
containing exons 4-8 of the H-2D' gene plus the pBR322 vector; these fragments were
purified from a 1 % agarose gel by electroelution followed by DEAE column chromatog-
raphy. The 1 .8 kb fragment was subcloned into the Xba I site of pUC13 (14), producing
pDd-11 .
The 1 .8 kb and 2.5 kb fragments resulting from complete digestion of clone X12a,
which encodes the H-2DP gene (13, 15), with Xba I and Bam HI, respectively, were
purified and subcloned into the Xba I site of pUC13 and the Bam HI site of pUC9 (14)
producing pDP-11, containing exons 1, 2, and 3, and pDP-21, containing exons 4-8 of the
H-2DP gene.
Clones pDd-I 1 and pDP-11 were now treated similarly: complete digestion with Sma I
produced a 3 .5 kb fragment containing exon 3 and the pUC13 vector, which was purified
as above; partial Sma I digestion gave fragments of 4.5 kb, 4.2 kb, 3.9 kb, 3 .5 kb, 1 .0 kb,
0.6 kb, and 0.3 kb; the 1 .0 kb band contains exons 1 and 2 and was purified as above .
The 1 .0 kb Sma I fragment from pDP-11 was now ligated with the 3.5 kb Sma I fragment
from pDd-11 and vice versa, producing clone a and clone b, respectively.
Exons 1, 2, and 3 were then removed from clones a and b on the 1 .8 kb Xba I
fragments and ligated into the 12 kb fragment produced by Xba I digestion of pDd-1 .
The other recombinant clones were produced by cutting pDP-21 with Hind III, filling in
the 5' protrusions with Klenow fragment and blunt-end-ligating to the 1 .8 kb Xba I
fragment, which had been similarly filled in with Klenow fragment, from clone a, clone
b, pDd-1 and pDP-11 (see Fig. 1).
Production of Transformed Cell Lines Expressing Recombinant H-2 Genes.
￿
The recombi-
nant H-2Dd/H-2DP genes were transfected into mouse L cells (DAP-3) and transformedDARSLEY ET AL .
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FIGURE 1 .
￿
Recombination of exons between H-2D" and H-2D" genes . Exons are indicated
by boxes, open for those encoded by the D" gene and closed for those derived from the DP
gene . Restriction sites : x, Xho 1 ; b, Bam Hl ; s, Sma 1 ; h, Hind 111 .
clones were selected exactly as described previously (16) . Untransformed DAP cells for
use as negative controls were maintained in DMEM (Flow Laboratories, McLean, VA)
supplemented with 10% FCS, 2 mM glutamine, and 10 ug/ml gentamycin under an21 4
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atmosphere of 5% C02. Transformed cells were grown in the same medium supplemented
with HAT.
Monoclonal Antibodies. The mAbs used in this work, their specificities, and their
patterns of crossreactivity with other haplotypes has been described previously (12, 17).
Antibodies 135 and 218 were supplied by Dr. Kim Hasencrug, McLaughlin Research
Institute, Great Falls, MT.
Antibody Binding to Transformed Cells.
￿
Antibody binding to the cells containing the
recombinant H-2 genes was measured in an indirect radioimmunoassay, essentially as
described previously (12). Cells were harvested by trypsinization and plated out in 96-well
microtiter plates (Costar, Cambridge, MA) at densities of 0.8-1 .7 x 106 cells/ml in
volumes of 10.0 ,ul. After growing overnight, the cell layers were washed three times with
PBS containing 10% FCS (PBS/FCS), then incubated with 30 ,.l of mAb in tissue culture
supernatant, also containing 10% FCS, for 1 h at 4°C. This amount of antibody was
sufficient to ensure saturation ofantigens. After three more washes with PBS/FCS, bound
antibody was detected with 50 ul
of
￿
]-conjugated sheep anti-mouse immunoglobulin
(Amersham Corp., Arlington Heights, IL) at dilutions of 1 :100 to 1 :160 for 1 h at 4°C .
The unbound antibody was removed by three washes with PBS/FCS, after which cells
were lysed in 100 Al of 1 % NP-40 (BDH Chemicals Inc., Poole, United Kingdom). This
solution was harvested onto filter plugs using a titertek cell harvester (Flow Laboratories)
and ' 25I-labelled material was detected in a Beckman 5500 gamma counter. Alternatively,
for anti-H-2DP mAbs, 125I-protein A was substituted for anti-mouse IgG and plates were
cut and counted directly. For IgM antibodies, affinity-purified rabbit anti-mouse u chain
was used as an intermediate. All data points were determined in triplicate.
Results
Binding ofAnti-H-2Dd mAbs to Recombinant Class 1 Gene Products.
￿
The reactiv-
ity ofeach of the panel of anti-H-2Dd mAbs with transformed cell lines expressing
the exon-shuffled class I proteins, along with the domain assignment of each
epitope from these results and from previous experiments with Dd/Ld recombi-
nants (12) is shown in Table 1 . The results with the test antibodies and with the
controls 34 .5 .8 and 34 .2.12 indicate that the level of expression ofthe transfected
genes in the cell lines A3 (pdd), B22 (dpd), and D1 (pdp) is somewhat lower than
in the others. Maximal binding of antibodies to these three lines appears to be
70-80% of that to C3, D23, and F12. Reactivity ofan antibody with a particular
cell line is considered to be significantly reduced if it is 20% or less of the binding
to C3, which expresses the wild type Dd molecule.
The domain assignments from the new Dd/DP recombinants generally confirm
those made previously (12), or resolve ambiguities in them. Antibodies TO . 101,
TO. 102, and TO. 103, previously known to crossreact with cells from mice of the
H-2P haplotype, do not bind to the DP molecule expressed on cell line F12, which
suggests that they are crossreactive with the KP molecule. Antibodies TO . 112,
TO. 113, TO. 114, TO. 117, TO. 121, and TO. 123, which were previously shown
to recognize epitopes either within C 1 or dependent upon both N and C 1, on
the basis of these new recombinants, have epitopes wholly within C1 . Antibody
T0 .138, on the contrary, previously indistinguishable from these mAbs, recog-
nizes an epitope dependent on both domains.
The results for some of the anti-H-2D' antibodies with the D'/DP recombi-
nants, however, yield new information concerning their specificities not previ-
ously revealed by the experiments with the Dd/Ld recombinants. 12 mAbs,
namely TO. 108, TO. 109, TO. 116, TO. 126, TO. 127, TO. 132, TO. 134, TO. 135,
TO . 139, TO. 141, TO. 143, and TO . 145, whose epitopes were previously mappedDARSLEY ET AL.
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to the N domain of Dd, are now demonstrated to show greatly reduced (<20%)
binding to B22 cells expressing a construct where the N domain of Dd is placed
adjacent to the Cl domain of DP. A further six mAbs, TO. 104, TO. 115, TO . 122,
T0.128, T0 .142, and T0.144, show binding to B22 cells at 20-50% of the
control . All of these antibodies display full crossreactivity between the wild type
Dd molecule and a construct where the N domain of Dd is placed adjacent to the
C 1 domain of Ld (12) . This result implicates those positions in the C 1 domain
common to Dd and Ld but differing in DP as being involved in their epitopes (see
Discussion).
Antibodies TO. 110 and TO . I I I display curious patterns of reactivity. The
binding of T0.110 to cell lines A3 and D1 (N-DP, C1-Dd) is very low, while it
binds at 50% of the control level to F12 (N-DP, C1-DP). Thus, substituting the N
domain abolishes binding, which can be partially restored by further substituting
the C l domain . The antibody recognizes both wild type molecules better than
any recombinant where the N or Cl domain has been substituted. TO . 111, on
the contrary, reacts with all recombinants (N-D
d, Cl-DP or N-DP, Cl-Dd), but
not with the wild type DP on F 12 cells.
Binding of Anti-H-2W mAbs to Recombinant Class I Gene Products.
￿
Table II
shows the reactivity of each of the anti-H-213P mAbs with the DP/Dd recombinants
and the assignment of their epitopes to particular domains based on these data.
Two antibodies, 7-30 .6 and 11-20.3, appear to react with epitopes dependent
solely upon the N domain of DP. In contrast, five antibodies, 5-7.1, 218, 7-30.2,
7-16 .10, and 135, require both N and C1 domains to be of DP origin in order to
bind. Antibody 6-27 .5 has a pattern of reactivity that is hard to explain in terms
of domain requirements. It shows broad crossreactivity with other class I mole-
cules (reference 17 and Table IV), which suggests that it recognizes a relatively
nonpolymorphic section of the molecule.
mAb Reactivity with Other Class I Molecules. Comparing the crossreactivity
profiles (12) of the 15 mAbs that are specific for complex epitopes involving
both N and C1 domains of H-2Dd (Table III A) shows that they have eight
distinct patterns of crossreactivity. As seven of these antibodies have private
specificities and therefore cannot be distinguished by such experiments, it is very
likely that more than eight distinct epitopes actually exist. Similarly, the five anti-
H-2DP mAbs specific for N/C1 complex-determinants display five distinct cross-
reactivity patterns (Table III B). Thus the anti-DP mAbs also recognize multiple
distinct epitopes in the region of interaction of the N and C l domains of the
class I molecule.
Discussion
Previous attempts to localize the epitopes recognized by alloantibodies or
CTLs on class I molecules have mostly addressed the question of which domain
or domains contain these epitopes (5-12). The results suggest that the great
majority ofCTLs recognize structures dependent on both the N and C 1 domains,
and are unaffected by the C2 domain . A high proportion of alloantibodies
recognize distinct determinants in the N and/or Cl domains, although some
mAbs have been characterized that see epitopes within the C2 domain (5, 7) .216
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TABLE I
Binding ofAnti-H-2D' mAbs to Cells Expressing Recombinant Class I Genes
mAb
Binding
(cp
*
by
C3
ddd
A3
pdd
Percent
B221
dpd
of cpm
D23
ddp
bound
D1
pdp
by C3$
F12
ppp
DAP
Domain assignment$
Ld/Dd DP/Dd
T0.101 4,264 0 1 89 0 0 0 - N,C1
TO.102 5,375 64 39 102 65 95 0 - -
T0.103 4,814 64 73 87 68 102 0 N -
T0 .104 3,490 1 23 79 0 1 0 N N(CI)
TO.105 1,251 2 11 104 2 7 1 - N,C1
TO.106 6,523 74 0 91 73 1 0 - CI
TO. 107 4,383 1 66 93 0 0 0 N N
TO. 108 1,195 1 12 106 3 8 2 N N,CI
TO.109 1,338 3 13 105 3 7 1 N N,CI
TO.110 1,097 5 27 110 8 47 2 N -
T0.111 3,865 76 57 98 68 0 0 N -
T0.112 3,876 77 1 112 73 0 0 C1/N, C1 C1
TO.113 3,726 74 1 119 72 0 0 C1/N, C1 C1
TO.114 3,588 83 1 104 76 1 1 C1/N, C1 CI
TO. 115 5,212 0 38 98 0 1 1 N N(C1)
TO. 116 753 3 3 107 2 1 4 N N,C1
TO. 117 5,505 65 0 113 64 0 1 C1/N, C1 C1
TO. 119 5,441 0 83 79 1 1 1 N N
TO. 120 4,611 1 51 71 0 0 0 N N
TO. 121 5,195 86 1 112 82 0 0 C1/N, C1 C1
TO. 122 861 1 48 104 1 6 2 N N(C1)
TO. 123 5,764 67 0 94 76 0 0 C1/N, CI C1
TO. 124 4,718 1 74 91 0 1 1 N N
TO. 126 861 3 2 98 1 3 2 N N,C1
TO. 127 871 3 16 78 5 3 1 N N,C1
TO. 128 3,615 0 24 93 1 1 1 N N(C1)
TO. 129 5,764 0 82 89 0 0 0 N N
TO. 130 3,731 7 71 101 7 0 1 N N
TO. 131 3,266 0 70 81 1 0 1 N N
T0.132 3,124 0 1 89 0 1 1 N N,C1
T0.133 3,349 1 70 80 1 1 1 N N
T0.134 4,992 1 0 81 0 1 1 N N,CI
TO. 135 2,301 1 8 90 2 1 1 N N,CI
TO. 136 5,024 0 74 87 0 0 1 N N
T0.137 5,961 0 67 92 1 1 0 N N
TO. 138 4,101 1 3 92 0 0 0 C1/N, C1 N,C1
TO. 139 621 2 14 51 0 2 4 N N,CI
TO. 141 5,142 0 0 82 1 0 1 N N,C1
TO. 142 427 2 39 59 8 7 2 N N(C1)
TO. 143 329 4 12 68 0 1 0 N N,C1
TO. 144 3,087 1 32 92 0 0 0 N N(C1)
TO. 145 4,178 0 3 83 0 0 0 N N,C1
34.5.8 5,713 77 0 114 73 0 0 C1 C1
34.2.12 5,035 86 65 0 0 0 0 C2 C2
16.1 .2 4,509 121 110 97 106 97 87 Dk/Kk Dk/Kk
Medium' 1 0 0 1 0 0 1DARSLEY ET AL.
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Domain compositions of expressed class I antigens and domain assignments of epitopes are as
describedfor TableI. Binding of an irrelevant, KP-specific antibody, 7-16.4, was always <10% of the
bindingof a K'-specific positive control to each transfected cell line.
This implies a certain level of dichotomy between the epitopes on class I antigens
recognized by mAbs and CTLs.
This study further investigated the specifcities ofa panel of anti-H-2Dd mAbs
previously characterized according to their reactivities with Dd/Ld recombinants,
now using Dd/DP recombinants. Comparison of the data from the experiments
with the two sets of recombinants allows the nature of the mAb epitopes to be
analyzed in more detail than is possible from either set alone. The particular
pattern of polymorphism manifest in class I antigens, where many positions are
variable but a relatively low number of amino acid variants is seen at any one
position, means that any two class I antigens will share the same residues at a
number of polymorphic positions. Analysis of mAb (or CTL) specificities using
a single set of exon-shuffled products is thus limited by the fact that the exchanged
exons may be identical in positions recognized by certain mAbs (or CTLs). This
problem can be minimized by using recombinants made from more than two
genes, as is clearly demonstrated in this work. The limited number of positions
at which any pair of class I molecules differ is now an advantage as it allows an
assessment of the contributions of individual amino acids to the antigenic struc-
ture of the molecules.
In this work, we have shown that a high proportion of mAbs (at least 20 out
of 49) recognizing the N and/or C 1 domains of the Dd or DP molecules are
actually specific for epitopes the integrity of which requires both of these two
domains. The same phenomenon has been observed in the Kd/Kk system (8) . In
* The resultsrepresentthe mean of triplicate determinations.
$The domain compositions of therecombinant genesexpressed in cell lines C3, A3, B22, D23, D1,
F12, and DAP are indicated in the order: N, C1, C2 (d, Dd; p, DP).
§ Theepitope recognized by each antibody is assigned to one or two domainson the basis either of
previous experiments with Ld/Dd recombinants (12) or on the basis ofthe data presented here: N,
N domain; Cl, C1 domain; N,Cl, requiring residues in both domains; N(C1), N domain with a
possible contribution from C1 domain (20-50% of the control binding to B22 cells); Cl/N,Cl,
either C1 domain alone or N and C1 domains together.
Binding to B22 cells was determined in two independent experiments which gave very similar
results. Data from one of the two experiments are shown here.
' Binding (cpm) by medium control in the absence of primary antibody is expressedas a percentage
of bindingby mAb 16.1 .2, specific for the H-2k molecules constitutively expressed by DAP cells.
mAb
Binding
(cpm) by
F12
ppp
A3
pdd
Percent
B22
dpd
of cpm bound
C3
ddd
by F12
D1
pdp
D23
ddp
Domain
assignment
5-7.1 33,132 7 5 7 6 6 N,C1
218 20,274 12 10 12 10 13 N,C1
6-27.5 28,183 47 27 26 38 66 -
7-30.2 19,152 17 16 13 13 9 N,C1
7-30.6 23,586 93 25 27 71 18 N
11-20.3 9,629 158 16 36 121 17 N
7-16.10 28,051 2 12 2 2 1 N,C1
135 23,543 0 5 3 2 1 N,C1218
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TABLE III
Crossreactivity Profiles ofNCI-specific Antibodies
B.
* The mAbs are indicatedin theabbreviated form: TO. 101 as 01, etc. Aplus sign showscrossreactivity
measured by indirect radioimmunoassay for the N-D', C1-Ld, and N-Dd, C1-DP recombinants as
described in Materialsand Methods, or by flow cytofluorimetry for the otherantigens (12). Those
antibodies showing 20-50% bindingto B22 cells (dpd) are enclosed in parentheses.
addition, antibodies, both polyclonal and monoclonal, raised against a class I
molecule containing the N domain of DP and the C1 and other domains of Dd
recognize epitopes not present on either parental molecule . These neodetermi-
nants display a degree of immunodominance in the humoral response to the
hybrid molecule (Kanda, LuPan, Takahashi, Appella, and Frelinger, Immunoge-
netics, in press). These observations suggest that the interaction of the two
membrane-distal domains is of critical importance to the antigenic structure of
class I molecules. The analysis of the contacts between the N and C1 domains
will thus be ofgreat importance for an understanding ofclass I function.
By comparing the reactivities ofa large number of mAbs with two panels of
recombinant class I gene products (Dd/Ld and Dd/DP), we have been able to
begin to analyze the nature of the N/C1 domain interaction. The 15 anti-H-2Dd
mAbs and the five anti-H-2DP mAbs specific for N/Cl complex determinants
recognize at least 15 distinct epitopes, as revealed by their patterns ofcrossreac-
tivity with other H-2 haplotypes (Table III). This implies that the area of
interaction between N and C1 involves a significant portion ofboth domains.
18 of the anti-H-2Dd mAbs that were assigned as N domain-specific on the
Molecule
Monoclonal antibody*
01 05 08 09 16 26 27 32 34 35 38 39 41 43 45 (04 15 22 28 42 44)
Anti-14-2Dd
Dd + + + + + + + + + + + + + + + + + + + + +
Ld + +
N-Dd,CI-Ld + + + + + + + + + + + + + + + + + + + +
N-Dd,Cl-DP
DP
Db + +
Kd + + +
Kb + + + +
K°
KP +
H-2' + + + + + + + + +
H-29 + + + + + + + + +
H-2' + +
H-2t +
Anti-H-2DP 5-7.1 7-30.2 7-16.10 218 135
Dd
Ld
DP + + + + +
Db
Kd + + +
Kb
KP +
H-2'
H-29
H-2' + + +
H-2' + + +basis of their reactivities with H-2Dd/H-2Ld recombinants are now seen to show
reduced reactivity with the B22 cell line, which expresses a molecule which
derives its N domain from Dd but its C1 domain from DP. This implicates those
amino acid residues in the CI domain, where Dd and Ld are the same but DP is
different, as playing a key role in the epitopes recognized by these antibodies.
Fig. 2 shows that only at positions 5, 7, 17, 73, 83, 84, and 91 are these criteria
met. It is also possible that positions 9, 31, 65, and 66, where all three sequences
are different, may be involved. The nature ofthe substitutions at the latter three
positions, however, makes their involvement unlikely, as the changes in Ld
relative to Dd are at least as nonconservative as the changes in DP. The involve-
ment of some or all of these C1 residues in the mAb epitopes could be either
direct, if they actually formed a complex epitope with residues located in the N
domain and adjacent in the tertiary structure, or indirect, if the nature ofthese
residues in the C1 domain were responsible for conformational perturbations of
epitopic residues in the Ndomain. In either case, thedata presented here suggest
that these residues are located at positions in the structure intimately involved
in the interaction between the Nand C1 domains.
Crystallographic studies on the human class I antigens HLA.A2 and HLA.A28
are in progress (18). The most recent interpretation of the structure of the A2
molecule at high resolution reveals that what have been known as the N and C1
domains really are not domains in the strict sense, although we will continue to
refer to them as such. Instead they fold to form a single "superdomain." The
tertiary organization of this superdomain appears to be quite unlike that of the
classic immunoglobulin fold, which is displayed by the C2 domain and 02m
(Samraoui, Bjorkman, and Wiley, personal communication).
This information confirms the conclusion suggested by the results presented
in this paper; that there is a strong interaction between the N and C1 domains,
extending over a large area. It also suggests that residues in the C1 domain will
influence epitopic residues in the N domain by both direct and indirect means.
Recent studies (19, 20) have shown that the region of a protein antigen that
makes contact with the binding site of an antibody, i.e., constitutes an epitope,
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FIGURE 2 .
￿
Aminoacid sequences of CI domains of H-2Dd, H-2Ld, and H-213P. Residues are
numbered from the first position in the C1 domain, i.e., beginning at residue 91 when
numbered from the NH3 terminus of the complete molecule. A dot indicates identity to the
H-2D' sequence. Positions indicated with an asterisk are those where the Dd and Ld are the
same but DP is different; an open circle indicates the positions where all three sequences are
different. References: H-2D' (21), H-2DP (22), H-2Ld (23). The latter differs from the Ld
sequence in (24); it is given because it is the sequence of the clone from which the Ld/Dd
recombinants were generated.220
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may be up to 30 X 20A in size. Cl domain residues will clearly be within this
distance of N domain residues on the surface of the class I antigen if the two
domains actually fold into a single unit. They will also be in positions whereby
they might exert indirect effects on the conformations ofother residues.
The accumulating evidence points to the region of interaction of the N and
C1 domains as being ofprime importance for the immune recognition of class I
molecules by both antibodies and CTLs. The polymorphism ofclass I genes has
presumably been selected by evolution to maximize the potential for the recog-
nition of their products in association with foreign antigens by CTLs. Thus it is
probable that mutations causing changes in class I antigensat the sites recognized
by CTLs will be most likely to be preserved. We might therefore predict that
the more polymorphic regions of the class I sequences be clustered in the three-
dimensional structure in the region of the molecule recognized by CTLs, i.e., at
the region ofinteraction between the N,C1 domains. This hypothesis issupported
by the large proportion of mAbs that are also seen to recognize N, C1 complex
epitopes if suitable domain exchanges are performed, and which tend to be
directed towards the more polymorphic regions of the molecule by virtue of
their mode of production. The accuracy of these predictions will be revealed
when the complete high-resolution crystal structure of one or more class I
molecules is available.
Summary
The specificities of an extensive panel of anti-H-2D' monoclonal antibodies,
which had been previously characterized using exon-shuffled H-2Dd/H-2Ld
molecules and a number of anti-H-2131 ' antibodies, were examined using H-
2Dd/H-2DP recombinants. The use of this new family of recombinant antigens
revealed extensive interaction between the membrane-distal (Nand C1) domains
ofclass I molecules. 20 out of 48 mAbs recognize complex epitopes formed by
the interaction of these two domains. These antibodies exhibit a number of
distinct patterns of crossreactivity with other class I proteins, revealing the
presence ofmultiple epitopes within the region ofdomain interaction. Compar-
ison of the data presented here with those from previous work allowed the
identification ofa small number ofresidues in the CI domain that participate in
the generation of complex epitopes involving both the N and CI domains. The
results are discussed in terms of the structural information available for these
two domains.
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